The evolution of heart gene delivery vectors

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• Gene Therapy

Background:

• Gene therapy offers potential for treating heart diseases.
• Efficient and specific cardiac gene transfer is crucial for therapeutic success.
• Ideal vectors should exhibit low toxicity, minimal immunogenicity, and be manufacturable.

Purpose of the Study:

• To review the development and evolution of gene transfer vectors for cardiac applications.
• To highlight the advantages of adeno-associated virus (AAV) vectors in preclinical cardiac gene therapy models.

Main Methods:

• Review of scientific literature on gene transfer vectors for cardiac applications.
• Analysis of viral and nonviral vector characteristics for heart gene delivery.
• Evaluation of adeno-associated virus vector performance in animal models of heart disease.

Main Results:

• Various nonviral and viral vectors have been engineered for cardiac gene delivery.
• Adeno-associated virus vectors demonstrate significant potential for preclinical cardiac gene therapy.
• AAV vectors exhibit favorable features for efficient and persistent gene transfer in the heart.

Conclusions:

• Adeno-associated virus vectors are a promising tool for advancing cardiac gene therapy.
• Continued research into vector development is essential for successful clinical translation.
• Optimized gene transfer vectors are key to realizing the therapeutic potential of gene therapy for heart disease.